Carotid Artery Stenting Outcomes in the Standard Risk Population for Carotid Endarterectomy

Inclusion Criteria

• •1. Subject must be ≥ 18 years of age.
• •2. Subject does not have any condition that limits their anticipated survival to less than 3 years.
• •3. Subject or a legally authorized representative must provide written informed consent prior to any trial related procedure.
• •4. Subjects with neurological symptoms within 180 days of the procedure and ≥ 70% stenosis of the common or internal carotid artery by ultrasound or ≥ 50% stenosis of the common or internal carotid artery by angiogram - OR-
• •5. Subjects without neurological symptoms within 180 days of the procedure and ≥ 70% stenosis of the common or internal carotid artery by ultrasound or ≥ 60% stenosis of the common or internal carotid artery by angiogram.
• •6. Subject with all the following target vessel characteristics:
• •1. Discrete lesion in internal carotid artery (ICA) with or without involvement of the contiguous common carotid artery (CCA).
• •2. Vessel diameter ≥ 4.0 mm and ≤ 9.0 mm from reference or contralateral artery.
• •3. Absence of excessive vessel tortuosity that would impede delivery of devices.
• •7. Subject must agree not to participate in any other clinical trial for a period of 1 year following the index procedure.